You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Epstein-Barr Virus-specific Cytotoxic T lymphocyte (EBV-CTL)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus Trial in Houston (MABEL CTLs, Cyclophosphamide,

Recruiting
  • Hodgkin Disease
  • +5 more
  • MABEL CTLs
  • +2 more
  • Houston, Texas
  • +1 more
Jan 13, 2023

Acute Lymphocytic Leukemia, Lymphoma Trial in New York (Biological/Genetically Modified T cells, Cyclophosphamide-based chemo)

Active, not recruiting
  • Acute Lymphocytic Leukemia
  • Lymphoma
  • Biological/Genetically Modified T cells
  • Cyclophosphamide-based chemotherapy
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 3, 2023

Epstein-Barr Virus Infections, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)

Recruiting
  • Epstein-Barr Virus Infections
  • Primary Immune Deficiency Disorder
  • cytotoxic t-lymphocytes
  • Los Angeles, California
  • +7 more
Sep 27, 2022

Epstein-Barr Virus (EBV) Infections, Lymphoproliferative Disorders, EBV+ Associated Lymphoma Trial (tabelecleucel)

Available
  • Epstein-Barr Virus (EBV) Infections
  • +11 more
  • tabelecleucel
  • (no location specified)
Feb 15, 2022

CMV Infection, EBV Infection, Stem Cell Transplant Trial (Virus specific T cells)

Not yet recruiting
  • CMV Infection
  • +2 more
  • Virus specific T cells
  • (no location specified)
Oct 4, 2023

EBV Lymphoma, Post-transplant Lymphoproliferative Disease (PTLD) Trial in Switzerland (Donor-derived ex-vivo expanded EBV Tscm

Not yet recruiting
  • EBV Lymphoma
  • Post-transplant Lymphoproliferative Disease (PTLD)
  • Donor-derived ex-vivo expanded EBV Tscm CTL
  • Basel, Switzerland
  • +7 more
Jan 25, 2023

Adenovirus, Cytomegalovirus Infections, Epstein-Barr Virus Infections Trial in Pittsburgh (Specific T- Lymphocytes)

Not yet recruiting
  • Adenovirus
  • +2 more
  • Specific T- Lymphocytes
  • Pittsburgh, Pennsylvania
    UPMC Children's Hospital of Pittsburgh
Sep 8, 2023

Epstein-Barr Virus Infections, Adenovirus, Cytomegalovirus Infections Trial in Milwaukee (Cytotoxic T Lymphocytes)

Completed
  • Epstein-Barr Virus Infections
  • +2 more
  • Cytotoxic T Lymphocytes
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Oct 21, 2021

EBV Infection After Allogenic HSCT Trial in Beijing (EBV-TCR-T cells)

Recruiting
  • EBV Infection After Allogenic HSCT
  • EBV-TCR-T cells
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Nov 3, 2023

EBV-associated Hemophagocytic Lymphohistiocytosis, EBV Infection Trial in Beijing (EBV-TCR-T cells)

Recruiting
  • EBV-associated Hemophagocytic Lymphohistiocytosis
  • EBV Infection
  • EBV-TCR-T cells
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Nov 12, 2023

EBV Associated Extranodal NK/T-cell Lymphoma, EBV-Associated GastricCarcinoma or Esophageal AdenoCarcinoma Trial in Korea,

Recruiting
  • EBV Associated Extranodal NK/T-cell Lymphoma
  • EBV-Associated GastricCarcinoma or Esophageal AdenoCarcinoma
  • EBViNT Cell
  • Seoul, Gangnam-gu, Korea, Republic of
  • +7 more
Jul 7, 2022

EBV-positive Nasopharyngeal Carcinoma Trial in Guangzhou (Cohort A: 3.0x10^6 CAR-T cells/kg, Cohort B: 9.0x10^6CAR-T cells/kg,

Not yet recruiting
  • EBV-positive Nasopharyngeal Carcinoma
  • Cohort A: 3.0x10^6 CAR-T cells/kg
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 16, 2023

Epstein-Barr Virus Infections, Post-Transplant Lymphoproliferative Disorder, Lymphoma Trial in Montreal (Group A, Group B)

Recruiting
  • Epstein-Barr Virus Infections
  • +2 more
  • Group A
  • Group B
  • Montreal, Quebec, Canada
    Hôpital Maisonneuve-Rosemont
Apr 5, 2022

Serologically Active Adult Systemic Lupus Erythematosus Trial in Nantes, Paris (Autologous EBV specific CTL infusion)

Terminated
  • Serologically Active Adult Systemic Lupus Erythematosus
  • Autologous EBV specific CTL infusion
  • Nantes, France
  • +2 more
Mar 24, 2022

Adenovirus Infection, BK Virus Infection, Cytomegaloviral Infection Trial in Houston (Virus-specific Cytotoxic T-lymphocytes)

Recruiting
  • Adenovirus Infection
  • +6 more
  • Virus-specific Cytotoxic T-lymphocytes
  • Houston, Texas
    M D Anderson Cancer Center
Jan 6, 2023

NonHodgkin Lymphoma, Lymphoproliferative Disorders, EBV Related Lymphoma Trial in Houston (EBVST Cells, Nivolumab)

Completed
  • NonHodgkin Lymphoma
  • +6 more
  • EBVST Cells
  • Nivolumab
  • Houston, Texas
  • +1 more
Jul 19, 2021

Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type, Classical Hodgkin Lymphoma Trial in Houston (CD30.CAR-EBVST cells)

Recruiting
  • Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
  • Classical Hodgkin Lymphoma
  • CD30.CAR-EBVST cells
  • Houston, Texas
  • +1 more
Jul 20, 2022

Viral Infections After HSCT Trial in Washington (VSTs)

Active, not recruiting
  • Viral Infections After HSCT
  • VSTs
  • Washington, District of Columbia
    Childrens National Medical Center
Aug 30, 2022

Epstein-Barr Virus Infections, Cytomegalovirus Infections, Adenovirus Trial in New York (Rapidly generated virus specific T

Not yet recruiting
  • Epstein-Barr Virus Infections
  • +3 more
  • Rapidly generated virus specific T (R-MVST) cells
  • New York, New York
    Columbia University Irving Medical Center
Feb 18, 2022

Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (PID LPD), EBV+

Recruiting
  • Epstein-Barr Virus (EBV)-Associated Diseases
  • +13 more
  • Tabelecleucel
  • Los Angeles, California
  • +39 more
Nov 9, 2022

BK Polyomavirus Trial in Philadelphia (BK-virus specific CTLs)

Recruiting
  • BK Polyomavirus
  • BK-virus specific CTLs
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Mar 15, 2022

Lymphoma, Hodgkin's Disease, Relapse Trial in Houston (TGFbeta resistant LMP-specific CTLs)

Active, not recruiting
  • Lymphoma
  • +3 more
  • TGFbeta resistant LMP-specific CTLs
  • Houston, Texas
  • +1 more
Dec 8, 2021

Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications,

Recruiting
  • Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)
  • +4 more
  • tabelecleucel
  • Duarte, California
  • +70 more
Jun 23, 2022

Epstein-Barr Virus Associated Lymphoproliferative Disorder, EBV-Related PTLD, EBV Related Non-Hodgkin's Lymphoma Trial in

Recruiting
  • Epstein-Barr Virus Associated Lymphoproliferative Disorder
  • +7 more
  • Nanatinostat in combination with valganciclovir
  • Birmingham, Alabama
  • +57 more
Aug 10, 2022

Multiple Sclerosis Trial in Nantes (Cellular therapy with EBV specific autologous CTL infusion)

Recruiting
  • Multiple Sclerosis
  • Cellular therapy with EBV specific autologous CTL infusion
  • Nantes, France
    University Hospital
Jan 27, 2021